James Young

James Young

President at
MedImmune Oncology, Inc.

Net worth: 567 807 $ as of 31/05/2026

73 year
Health Technology
Consumer Services
Finance

Profile

Currently, James F. Young occupies the position of Chairman of Novavax, Inc. and President at MedImmune Oncology, Inc. Dr. Young is also on the board of Sagimet Biosciences, Inc. and CannaRoyalty Corp. In his past career Dr. Young was Chairman of La Jolla Capital, Inc., Chairman, Chief Executive & Financial Officer at Targeted Microwave Solutions, Inc., President-Research & Development at MedImmune LLC, Director-Molecular Genetics Department at Smith Kline & French Laboratories Ltd. and Faculty Member at Icah School of Medicine at Mount Sinai. James F. Young received a doctorate from Baylor College of Medicine and an undergraduate degree from Villanova University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
31/12/2024 51,760 ( 0.03% ) 567 807 $ 31/05/2026

James Young active positions

CompaniesPositionStart
President -

Former positions of James Young

CompaniesPositionEnd
NOVAVAX, INC. Chairman 10/03/2025
SAGIMET BIOSCIENCES INC. Director/Board Member 13/07/2023
TARGETED MICROWAVE SOLUTIONS INC. Chief Executive Officer 01/11/2018
Director/Board Member 10/07/2013
Chief Tech/Sci/R&D Officer -
See the detail of James Young's experience

Training of James Young

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

77

1st degree connections

15

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies15

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Consumer Services

Finance

Health Technology

Consumer Services

Health Technology

Producer Manufacturing

Process Industries

Health Technology